DURHAM, N.C. & SAN FRANCISCO--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today the transmission of a live satellite feed of a clinical case performed in the United Kingdom to an audience of more than 1,000 interventional cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco.
